Jump to content

Automating Assay Data Analysis Along the Antibody Discovery Pipeline

PEGS EU, Barcelona, Spain
November 2, 2021

The discovery of antibody (Ab) therapeutics involves multiple stages from initial immunization or library screening through engineering and protein production, in which diverse assays are performed to test target binding affinity, protein expression and purity, cellular function, and beyond. Genedata Screener automates analysis of crucial common assays for antibody discovery and development. It reduces errors associated manual processing and copy-paste data transfer, thus increasing efficiency and ensuring higher result quality. Screener unifies analysis across the workflow and standardizes QC, harmonizing data between teams and facilitates result reporting and sharing. Screener is in productive use for Ab discovery workflows at leading biopharma organizations.


Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy